ArticleAME case reports2026
A case series of radiologically misdiagnosed visceral lymphatic malformations.
Article in AME case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Visceral lymphatic malformation (LM) was rare and was easily misdiagnosed on imaging. This study aims to explore the clinicopathological and imaging findings of a series of visceral LM. Cases Description: The clinicopathological and imaging [computed tomography (CT) and/or magnetic resonance imaging (MRI)] findings of 11 radiologically misdiagnosed visceral LM were reviewed. The median age was 34 years old, with a sex ratio (male:female) of 1.2:1. Most were asymptomatic and found incidentally. Their locations were the lung, liver, spleen, and pancreas. They were all cystic masses, with or without septa, and mainly showed fluid attenuation on unenhanced CT (one filled with gas), hypo-signal intensity (SI) on T1WI, and hyper-SI on T2WI with/without internal hypo-SI fibrous septa. The septa showed mild to moderate enhancement. These masses were misdiagnosed as congenital pulmonary airway malformation (CPAM), hepatic mesenchymal hamartoma, splenic cyst, pancreatic intraductal papillary mucinous neoplasms (IPMN), mucinous cystadenoma, serous cystadenoma, and pancreatic ductal adenocarcinoma. They were all excised surgically. The positive rates of D2-40, CD31, and F8 staining were 100%, 100%, and 83.3%, respectively. Conclusions: Visceral LM were all cystic masses (multicysts or unilocular); mainly showed hypo-attenuation on unenhanced CT, hypo-SI on T1WI, and hyper-SI on T2WI with internal thin and uniform hypo-SI septa showing mild to moderate enhancement. It commonly expressed D2-40, CD31, and F8. LM should be reminded of the differentiation of visceral cystic mass.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.